An optimal antitumor response by a novel CEA/CD3 bispecific antibody for colorectal cancers
An optimal antitumor response by a novel CEA/CD3 bispecific antibody for colorectal cancers
About this item
Full title
Author / Creator
Publisher
United States: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
United States: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Abstract
Background
CD3-based bispecific T cell engagers (bsTCEs) are one of the most promising bispecific antibodies for effective cancer treatments. To elicit target-specific T cell-mediated cytotoxicity, these bsTCEs contain at least one binding unit directed against a tumor antigen and another binding unit targeting CD3 in T cell receptor...
Alternative Titles
Full title
An optimal antitumor response by a novel CEA/CD3 bispecific antibody for colorectal cancers
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8220303
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8220303
Other Identifiers
ISSN
2516-4236
E-ISSN
2516-4236
DOI
10.1093/abt/tbab009
